Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-Mutant Lung Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-2062
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

BRAF Mutation Class and Clinical Outcomes—Letter

Clinical Cancer Research
Cancer ResearchOncology
2019English

BRAF Mutation Class and Clinical Outcomes—Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2015English

BRAF Mutation as a Biomarker in Colorectal Cancer

Advances in Genomics and Genetics
2015English

Prognostic Utility of BRAF Mutation in Papillary Thyroid Cancer

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2010English

BRAF V600E Mutant Colorectal Cancer Subtypes Based on Gene Expression

Clinical Cancer Research
Cancer ResearchOncology
2016English

Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients

Neoplasma
Cancer Research
2012English

OA12.06 Mutational Landscape of BRAF V600E Positive Lung Cancer Patients Following BRAF Directed Therapy Failure

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Targeting Autophagy in BRAF-Mutant Tumors

Cancer Discovery
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy